SCHEMBL4923299

SCHEMBL4923299

CCc1n[nH]c2ncnc(O)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18588897 0.87 ALDH1A1 (0.31)
SCHEMBL4925835 0.86 HCAR2 (0.33)
SCHEMBL1128852 0.79 CHEK1 (0.40)
SCHEMBL3255707 0.78 LMNA (0.40)
SCHEMBL9918631 0.76 CCR4 (0.44)
SCHEMBL4922463 0.76
SCHEMBL4932404 0.76 SMN1; SMN2 (0.32)
SCHEMBL13111766 0.75
SCHEMBL15680396 0.72 GABRA1 (0.32)
SCHEMBL6433606 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076338-B2 Such as 6-(4-phenylpiperazin-1-yl)-9H-purine; cell proliferation/differentiation EXELIXIS, INC. (US) 2011-12-13 US disclosed
US-20080076774-A1 Kinase Modulators and Methods of Use EXELIXIS, INC. (US) 2008-03-27 US disclosed
EP-1750727-A2 KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2007-02-14 EP disclosed
WO-2005117909-A2 KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-12-15 WO disclosed